Annual Current Liabilities
$16.77 M
+$186.00 K+1.12%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual total current liabilities is $16.77 million, with the most recent change of +$186.00 thousand (+1.12%) on December 31, 2023.
- During the last 3 years, EWTX annual current liabilities has risen by +$12.43 million (+286.25%).
- EWTX annual current liabilities is now at all-time high.
Performance
EWTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.96 M
+$1.78 M+10.37%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly total current liabilities is $18.96 million, with the most recent change of +$1.78 million (+10.37%) on September 30, 2024.
- Over the past year, EWTX quarterly current liabilities has increased by +$2.62 million (+16.03%).
- EWTX quarterly current liabilities is now at all-time high.
Performance
EWTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EWTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | +16.0% |
| 3 y3 years | +286.3% | +16.0% |
| 5 y5 years | +1381.5% | +16.0% |
EWTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.4% | at high | +105.7% |
| 5 y | 5-year | at high | +1381.5% | at high | +336.6% |
| alltime | all time | at high | +1381.5% | at high | +336.6% |
Edgewise Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.96 M(+10.4%) |
| Jun 2024 | - | $17.18 M(+17.6%) |
| Mar 2024 | - | $14.60 M(-12.9%) |
| Dec 2023 | $16.77 M(+1.1%) | $16.77 M(+2.7%) |
| Sep 2023 | - | $16.34 M(+13.5%) |
| Jun 2023 | - | $14.40 M(+13.3%) |
| Mar 2023 | - | $12.71 M(-23.3%) |
| Dec 2022 | $16.59 M | $16.59 M(+24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $13.30 M(+44.3%) |
| Jun 2022 | - | $9.22 M(-7.9%) |
| Mar 2022 | - | $10.00 M(-4.9%) |
| Dec 2021 | $10.52 M(+142.3%) | $10.52 M(+20.2%) |
| Sep 2021 | - | $8.75 M(+29.9%) |
| Jun 2021 | - | $6.74 M(+38.9%) |
| Mar 2021 | - | $4.85 M(+11.7%) |
| Dec 2020 | $4.34 M(+283.6%) | $4.34 M |
| Dec 2019 | $1.13 M | - |
FAQ
- What is Edgewise Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual current liabilities year-on-year change?
- What is Edgewise Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly current liabilities year-on-year change?
What is Edgewise Therapeutics annual total current liabilities?
The current annual current liabilities of EWTX is $16.77 M
What is the all time high annual current liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual total current liabilities is $16.77 M
What is Edgewise Therapeutics annual current liabilities year-on-year change?
Over the past year, EWTX annual total current liabilities has changed by +$186.00 K (+1.12%)
What is Edgewise Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of EWTX is $18.96 M
What is the all time high quarterly current liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly total current liabilities is $18.96 M
What is Edgewise Therapeutics quarterly current liabilities year-on-year change?
Over the past year, EWTX quarterly total current liabilities has changed by +$2.62 M (+16.03%)